Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$26.0 - $37.03 $2,444 - $3,480
-94 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$27.5 - $38.19 $20,350 - $28,260
-740 Reduced 88.73%
94 $3,000
Q1 2021

May 11, 2021

BUY
$32.52 - $61.53 $24,877 - $47,070
765 Added 1108.7%
834 $29,000
Q4 2020

Feb 08, 2021

BUY
$35.51 - $54.03 $2,450 - $3,728
69 New
69 $3,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $565M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Jacobi Capital Management LLC Portfolio

Follow Jacobi Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.